Pathology Analysis & Statistics, May 2013 (p50)

Talk to Louis

+1 718 618 4302

Search inside this page

Publishers

All regions

You might be interested in: cancer, breast cancer, prostate cancer, more »

1471-1520 of about 6 000 reports

Purchase Reports From Reputable Market Research Publishers

Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2014

Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • February 2014
  • by Global Data

Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic ...

  • Industries : Pathology
  • Countries : World, United States
B-Cell Lymphomas Global Clinical Trials Review, H1, 2014

B-Cell Lymphomas Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • February 2014
  • by Global Data

B-Cell Lymphomas Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “B-Cell Lymphomas Global Clinical Trials Review, H1, 2014" provides data on the B-Cell Lymphomas ...

  • Industries : Pathology
  • Countries : World
Sanofi Pasteur SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sanofi Pasteur SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2014
  • by Global Data

Summary Sanofi Pasteur SA (Sanofi Pasteur) is a biotechnology company. The company manufactures human vaccines. It provides protection against 20 bacterial and viral diseases. The company provides vaccines ...

  • Industries : Pathology
  • Countries : United States
Anadys Pharmaceuticals, Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile, Global Data

Anadys Pharmaceuticals, Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile, Global Data

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

Summary Anadys Pharmaceuticals, Inc. (Anadys) is a biopharmaceutical company that develops novel therapeutics for the treatment of chronic hepatitis C viral infections. The products developed by the company ...

  • Industries : Pathology
  • Countries : World, United States
Les Laboratoires Servier SAS - Strategic SWOT Analysis Review

Les Laboratoires Servier SAS - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • February 2014
  • by Global Data

Les Laboratoires Servier SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a ...

  • Industries : Pathology
  • Countries : Canada, France
Neuren Pharmaceuticals Limited (NEU) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Neuren Pharmaceuticals Limited (NEU) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

Summary Neuren Pharmaceuticals Limited (Neuren Pharma) is a biopharmaceutical drug developer. The company develops drugs for brain injury and neurodegeneration. Its products under clinical development ...

  • Industries : Pathology
Soligenix, Inc. (SNGX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Soligenix, Inc. (SNGX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

Summary Soligenix, Inc. (Soligenix) is a development stage biopharmaceutical company involved in the development of products to treat serious inflammatory diseases and biodefense countermeasures. The company ...

  • Industries : Pathology
  • Countries : United States
GlaxoSmithKline plc (GSK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlaxoSmithKline plc (GSK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

Summary GlaxoSmithKline plc (GSK) is a healthcare company. It focuses on the development, manufacture and commercialization of pharmaceutical and consumer health related products. The company offers medicines ...

  • Industries : Pathology
Microbix Biosystems Inc. (MBX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Microbix Biosystems Inc. (MBX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

Summary Microbix Biosystems Inc. (Microbix) is a biotechnology service provider. The company develops biological products and technologies. Its products include chlamydia trachomatis, chlamydophila pneumoniae, ...

  • Industries : Pathology
  • Countries : Canada
Exelixis, Inc. (EXEL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Exelixis, Inc. (EXEL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

Summary Exelixis, Inc. (Exelixis) is a biotechnology company. It is focused on the development of pharmaceutical products for treatment of cancer and other life threatening diseases. The company's lead ...

  • Industries : Pathology
  • Countries : United States, Sweden
EpiCast Report: Major Depressive Disorder - Epidemiology Forecast to 2023

EpiCast Report: Major Depressive Disorder - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • February 2014
  • by Global Data

EpiCast Report: Major Depressive Disorder - Epidemiology Forecast to 2023 Summary Major depressive disorder (MDD), also known as clinical depression or major depression, is widely recognized as one of ...

  • Industries : Pathology
  • Countries : World, Australia, Spain, Italy, France, Germany, Japan
Global Infectious Diseases Therapeutics Market—Influenza, RSV, Chlamydia, and Gonorrhoea

Global Infectious Diseases Therapeutics Market—Influenza, RSV, Chlamydia, and Gonorrhoea

  • $ 4 500
  • Industry report
  • February 2014
  • by Frost & Sullivan

Persistent Unmet Need for Treatment Fuels Novel Antiviral/Antibacterial Drug Development RSV Antivirals • Ribavirin, the only approved antiviral directed at the human respiratory syncytial virus (RSV), ...

  • Industries : Pathology
  • Countries : World
NeuroSearch AS (NEUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

NeuroSearch AS (NEUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

Summary NeuroSearch A/S (NeuroSearch) is a biopharmaceutical company that develops novel pharmaceutical agents for the treatment of various life threatening diseases. It mainly focuses on finding treatment ...

  • Industries : Pathology
Neurocrine Biosciences, Inc. (NBIX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Neurocrine Biosciences, Inc. (NBIX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

Summary Neurocrine Biosciences, Inc. (Neurocrine) is a bio-pharmaceutical company. It discovers, develops and commercializes innovative pharmaceutical products for the treatment of neurological and en ...

  • Industries : Pathology
  • Countries : United States
MediciNova, Inc. (MNOV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

MediciNova, Inc. (MNOV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

Summary MediciNova, Inc. (MediciNova) is a bio pharmaceutical company with focus on the acquiring and developing and commercializing novel, small-molecule therapeutics for the treatment of diseases with ...

  • Industries : Pathology
  • Countries : United States
NewLink Genetics Corporation (NLNK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

NewLink Genetics Corporation (NLNK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

Summary NewLink Genetics Corporation (NewLink) is a late-stage biopharmaceutical company. It identifies, develops and commercializes immunotherapeutic products for the treatment of cancer. NewLink's product ...

  • Industries : Pathology
  • Countries : United States
Pozen, Inc. (POZN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Pozen, Inc. (POZN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

Summary Pozen, Inc. (Pozen) is a progressive pharmaceutical company. It develops combination therapies for various therapeutic areas with particular focus on pain and pain related conditions. The company's ...

  • Industries : Pathology
  • Countries : United States
Nuvilex, Inc. (NVLX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Nuvilex, Inc. (NVLX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2014
  • by Global Data

Summary Nuvilex, Inc. (Nuvilex) is a pharmaceutical company. The company develops, manufactures, and markets natural components and biotechnology products for human, animal and environmental health. Nuvilex's ...

  • Industries : Pathology
  • Countries : United States, Austria
Patrys Limited (PAB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Patrys Limited (PAB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

Summary Patrys Limited (Patrys) is a pharmaceutical company. The company commercializes its technologies to develop natural human antibody-based therapeutic products for the treatment of cancer and many ...

  • Industries : Pathology
Agenus, Inc. (ACRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Agenus, Inc. (ACRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

Summary Agenus, Inc. (Agenus), formerly Antigenics, Inc., is a developer of therapeutic vaccines for cancer and infectious diseases. It develops and commercializes technologies and products to treat various ...

  • Industries : Pathology
  • Countries : United States
AEterna Zentaris Inc. (ABC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

AEterna Zentaris Inc. (ABC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

Summary AEterna Zentaris Inc. (Aeterna Zentaris) is a late stage drug development company. It carries out the development of therapeutics for the treatment of cancer, endocrine disorders and infectious ...

  • Industries : Pathology
Callisto Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile, Global Data

Callisto Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile, Global Data

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

Summary Callisto Pharmaceuticals, Inc. (Callisto) is a development stage biopharmaceutical company. It focuses on the development of drugs indicated to treat gastrointestinal disorders and diseases. The ...

  • Industries : Pathology
  • Countries : World, United States
Alseres Pharmaceuticals, Inc. (AMRN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Alseres Pharmaceuticals, Inc. (AMRN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

Summary Alseres Pharmaceuticals, Inc. (Alseres) is a development stage biotechnology company. It focuses on developing diagnostic and therapeutic products indicated to treat disorders in the central nervous ...

  • Industries : Pathology
  • Countries : United States
Alkermes Plc (ALKS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Alkermes Plc (ALKS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

Summary Alkermes Plc (Alkermes), formerly Alkermes Inc., is a biotechnology company. It undertakes the development and manufacturing of pharmaceuticals for the treatment of attention deficit hyperactivity ...

  • Industries : Pathology
CardioDx, Inc. - Strategic SWOT Analysis Review

CardioDx, Inc. - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • February 2014
  • by Global Data

CardioDx, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, ...

  • Industries : Pathology
  • Countries : United States
Asian American Medical Group Limited (AJJ) - Financial and Strategic SWOT Analysis Review

Asian American Medical Group Limited (AJJ) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • February 2014
  • by Global Data

Asian American Medical Group Limited (AJJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been ...

  • Industries : Pathology
  • Countries : United States
Breast Cancer: New targeted therapies transform treatment - KOL Insight

Breast Cancer: New targeted therapies transform treatment - KOL Insight

  • $ 4 995
  • Industry report
  • February 2014
  • by Firstword Pharma

Introduction The introduction of targeted therapies revolutionised the breast cancer market, widening clinical options and bringing improved survival rates and lower side effects for patients. Now the ...

  • Industries : Pathology
  • Countries : United States
EpiCast Report: Migraine - Epidemiology Forecast to 2023

EpiCast Report: Migraine - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • February 2014
  • by Global Data

EpiCast Report: Migraine - Epidemiology Forecast to 2023 Summary Migraine is typically characterized by recurring headaches, throbbing pain on one side of the head along with one or more of the following ...

  • Industries : Pathology
  • Countries : World, Japan, United States, Spain, Italy, France, Germany
Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive towards Personalized Treatment and Market Growth

Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive towards Personalized Treatment and Market Growth

  • $ 3 500
  • Industry report
  • February 2014
  • by GBI Research

Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive towards Personalized Treatment and Market Growth Summary GBI Research, a leading business intelligence provider, ...

  • Industries : Pathology
  • Countries : World
Gen-Probe Incorporated - Strategic SWOT Analysis Review

Gen-Probe Incorporated - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • February 2014
  • by Global Data

Gen-Probe Incorporated - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed ...

  • Industries : Pathology
  • Countries : Canada

About 200 Companies

Read our Company Profiles

Novartis Inc.

Switzerland

GlaxoSmithKline P.L.C.

United States

GlaxoSmithKline PLC

United Kingdom

Eli Lilly and Co.

United States

Pfizer Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.